SHENZHEN - Immunother Limited today announced that they will enter into a strategic research and development partnership that will specialize in 3D tissue regeneration.
SHENZHEN - Immunother Limited today announced that they are looking into developing medical solid-state imaging sensors to study the human body in extreme detail.
SHENZHEN - Immunother Limited announced today its Research and Development team will collect convalescent plasma from patients previously identified with COVID-19.
SHENZHEN - Immunother Limited today inaugurated their new Life Sciences Lab to accelerate their science through access to advanced technologies, services and training.
SHENZHEN - Immunother Limited today released a report on the growth of the global vitamin supplements market and it is estimated to hit US$160 billion by 2026.
SHENZHEN - Immunother Limited today announced that they will be holding a Virtual 3D Cell Model Conference next month with detailed research in 3D cell model development.
Immunother Limited today released findings on its Global T-Cell Immunotherapy Report which intends to offer a fresh outlook with opinions from industry experts.
SHENZHEN - Immunother Limited today announced that they have been studying enzymes to break down mucus in the stomach could provide analysis for intestinal diseases.
Immunother today published a report on the research and deeper understanding of why pancreatic cancer spreads and why it is most commonly found in the liver.
SHENZHEN - Immunother Ltd, a Shenzhen-based biotechnology company today announced its immuno-oncology programs to obtain key data on accuracy, efficacy and safety.
Satisfied Users & 
Approved Press Releases
